FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

6 results

deflazacort
(Deflazacort)
Sun Pharmaceutical Industries Limited
Usage: Deflazacort tablets are indicated for treating Duchenne muscular dystrophy (DMD) in patients aged 5 years and older. Additional pediatric information is available but not included on the label due to marketing exclusivity rights.
elevidys
(delandistrogene moxeparvovec-rokl)
Sarepta Therapeutics, Inc.
Usage: ELEVIDYS is indicated for treating Duchenne muscular dystrophy (DMD) in individuals aged 4 and older, including both ambulatory patients with a confirmed DMD gene mutation and non-ambulatory patients. The latter indication is approved under accelerated provisions based on the expression of micro-dystrophin in skeletal muscle.
emflaza
(deflazacort)
PTC Therapeutics, Inc.
Usage: EMFLAZA is indicated for treating Duchenne muscular dystrophy (DMD) in patients aged 2 years and older.
exondys 51
(eteplirsen)
Sarepta Therapeutics, Inc.
Usage: EXONDYS 51 is indicated for treating Duchenne muscular dystrophy (DMD) in patients with a confirmed mutation of the DMD gene suitable for exon 51 skipping. Its approval is based on observed increases in dystrophin in skeletal muscle, pending further verification of clinical benefit in ongoing trials.
viltepso
(viltolarsen)
NS Pharma, Inc.
Usage: VILTEPSO is indicated for treating Duchenne muscular dystrophy (DMD) in patients with a confirmed DMD gene mutation suitable for exon 53 skipping. Approval is based on increased dystrophin production in skeletal muscle, with continued approval dependent on further verification of clinical benefits.
vyondys 53
(golodirsen)
Sarepta Therapeutics, Inc.
Usage: VYONDYS 53 is indicated for treating Duchenne muscular dystrophy (DMD) in patients with a confirmed DMD gene mutation suitable for exon 53 skipping. Approval is based on increased dystrophin production in skeletal muscle, with continued approval dependent on clinical benefit verification in further trials.

Medications for Muscular Dystrophy Duchenne

deflazacort

elevidys

emflaza

exondys 51

viltepso

vyondys 53